Shares of vaccine-related stocks are trading higher following the latest bird flu developments, as well as a rise in respiratory illness. Novavax has a bird flu vaccine in clinical trials in addition to a COVID-19/influenza combination vaccine in late-stage trials.
Category
🗞
NewsTranscript
00:00♪♪♪
00:10♪♪♪
00:20♪♪♪
00:30♪♪♪
00:40♪♪♪
00:50♪♪♪